We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.1B
AUM Growth
-$134M
(-0.56%)
Cap. Flow
-$2.11B
Cap. Flow
% of AUM
-8.76%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$157M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
Salesforce
CRM
|
+$135M |
| 4 |
IBM
IBM
|
+$130M |
| 5 |
Dell
DELL
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$313M |
| 2 |
Apple
AAPL
|
+$207M |
| 3 |
Intel
INTC
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$159M |
| 5 |
Centene
CNC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.31% |
| 2 | Technology | 17.95% |
| 3 | Communication Services | 13.61% |
| 4 | Consumer Discretionary | 12.67% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Fortis
FTS
$28.7B
| $598K | ﹤0.01% |
13,500
-28,800
| -68% | -$1.3M |
|
1127
Imperial Oil
IMO
$60.4B
| $598K | ﹤0.01% |
19,601
-35,533
| -64% | -$1.07M |
|
|
HHR
1128
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $598K | ﹤0.01% |
+14,147
| New | +$546K |
|
1129
Columbus McKinnon
CMCO
$584M
| $591K | ﹤0.01% |
12,256
-7,588
| -38% | -$389K |
|
1130
Capital Southwest
CSWC
$1.6B
| $591K | ﹤0.01% |
+25,436
| New | +$631K |
|
1131
Cameco
CCJ
$42.4B
| $583K | ﹤0.01% |
30,382
-114,524
| -79% | -$2.16M |
|
|
FYBR
1132
DELISTED
Frontier Communications
FYBR
| $581K | ﹤0.01% |
+21,990
| New | +$554K |
|
1133
TFI International
TFII
$11.5B
| $581K | ﹤0.01% |
6,356
-78,322
| -92% | -$6.82M |
|
1134
Nektar Therapeutics
NKTR
$2.58B
| $579K | ﹤0.01% |
+2,248
| New | +$622K |
|
1135
Euroseas
ESEA
$531M
| $576K | ﹤0.01% |
+30,630
| New | +$430K |
|
1136
Upland Software
UPLD
$15.4M
| $574K | ﹤0.01% |
1,395
-2,428
| -64% | -$1.07M |
|
1137
Lumentum
LITE
$69.3B
| $571K | ﹤0.01% |
6,956
-12,062
| -63% | -$1.01M |
|
|
ALTA
1138
DELISTED
Altabancorp
ALTA
| $570K | ﹤0.01% |
+13,172
| New | +$575K |
|
|
KDNY
1139
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $568K | ﹤0.01% |
+40,233
| New | +$644K |
|
1140
Warrior Met Coal
HCC
$4.86B
| $567K | ﹤0.01% |
+32,990
| New | +$575K |
|
1141
AdvanSix
ASIX
$444M
| $565K | ﹤0.01% |
18,914
-20,415
| -52% | -$613K |
|
|
AMRS
1142
DELISTED
Amyris Inc.
AMRS
| $563K | ﹤0.01% |
+34,394
| New | +$513K |
|
1143
American Express
AXP
$230B
| $562K | ﹤0.01% |
3,401
+1,100
| +48% | +$172K |
|
|
ATCO
1144
DELISTED
Atlas Corp.
ATCO
| $560K | ﹤0.01% |
39,290
+22,702
| +137% | +$315K |
|
1145
Criteo S.A. Ordinary Shares
CRTO
$923M
| $556K | ﹤0.01% |
12,290
-13,483
| -52% | -$519K |
|
1146
Manulife Financial
MFC
$73.5B
| $556K | ﹤0.01% |
28,230
-390,631
| -93% | -$8.18M |
|
1147
KE Holdings
BEKE
$18.8B
| $555K | ﹤0.01% |
11,624
-7,410
| -39% | -$379K |
|
1148
LiveOne
LVO
$58.2M
| $554K | ﹤0.01% |
11,731
+2,479
| +27% | +$108K |
|
|
ACC
1149
DELISTED
American Campus Communities, Inc.
ACC
| $550K | ﹤0.01% |
11,758
+3,692
| +46% | +$171K |
|
1150
Lamar Advertising Co
LAMR
$16.3B
| $547K | ﹤0.01% |
5,234
-1,238
| -19% | -$126K |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.
- Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
- Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
- Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
- Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
- Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
- Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
- Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.
Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.